# Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery

> **NCT06881550** · NA · ENROLLING_BY_INVITATION · sponsor: **Caigang Liu** · enrollment: 2000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Shenbailing

## Key facts

- **NCT ID:** NCT06881550
- **Lead sponsor:** Caigang Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-12-30
- **Primary completion:** 2025-12-10
- **Final completion:** 2026-12-10
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881550, "Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06881550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*